ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
1
views
0
references
Top references
cited by
5
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,616
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
A phase II study of penpulimab, an anti-PD-1 antibody, in patients with relapsed or refractoryclassic Hodgkin lymphoma (cHL)
Author(s):
Y. SONG
,
K Zhou
,
C JIN
,
Z QIAN
,
M. Hou
,
L Fan
,
F LI
,
K Ding
,
H Zhou
,
X Li
,
C Jin
,
Yuqin Song
,
Keshu Zhou
,
Chuan Jin
,
Zhengzi Qian
,
Ming Hou
,
Lei Fan
,
Fei Li
,
Kaiyang Ding
,
Hui Zhou
,
Xiaoling Li
,
Bing Chen
,
Xiuhua Sun
,
Xianmin Song
,
Ming Jiang
,
Qingyuan Zhang
,
Xiaoping Jin
,
Zhongmin Maxwell Wang
,
Baiyong Li
,
Yu Xia
,
Jun Zhu
,
Z Qian
,
L. FAN
Publication date:
2021
Journal:
J Clin Onco
Read this article at
ScienceOpen
Publisher
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Gamma Delta T cells
Author and article information
Journal
DOI::
10.1200/JCO.2021.39.15_suppl.7529
ScienceOpen disciplines:
Immunology
Data availability:
ScienceOpen disciplines:
Immunology
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,616
Disitamab vedotin (RC48) combined with penpulimab (AK105) for neoadjuvant treatment of HER2-low breast cancer
Authors:
A phase ii study of the anti-programmed cell death-1 (Pd-1) antibody penpulimab in patients with metastatic nasopharyngeal carcinoma (NPC) who had progressed after two or more lines of chemotherapy
Authors:
X. Chen
,
W. Wang
,
Q. ZOU
…
Penpulimab: First Approval
Authors:
Sohita Dhillon
See all similar
Cited by
5
Penpulimab, an Fc-Engineered IgG1 Anti-PD-1 Antibody, With Improved Efficacy and Low Incidence of Immune-Related Adverse Events
Authors:
Zhaoliang Huang
,
Xinghua Pang
,
Tingting Zhong
…
Penpulimab: First Approval
Authors:
Sohita Dhillon
Novel Agents For Relapsed and Refractory Classical Hodgkin Lymphoma: A Review
Authors:
Yujie Zhang
,
Zhichao Xing
,
Li Mi
…
See all cited by